Intravascular Ultrasound Prediction of Myocardial Size and Coronary Computed Tomography-Derived Ischemic Burden for Coronary Lesion
- Conditions
- Coronary Artery Disease
- Interventions
- Other: Intravascular Ultrasound, coronary computed tomography angiography
- Registration Number
- NCT02845505
- Lead Sponsor
- Asan Medical Center
- Brief Summary
The aims of this study are 1) to identify IVUS determinants of the CAMS-derived myocardial territories subtended to the diseased vessels, 2) to find IVUS determinant for the extent of CAMS-derived myocardial size, and 3) to develop the mathematical model that integrates the IVUS information about myocardial territory and stenosis severity and predicts the extent of CAMS-derived myocardial size.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ACTIVE_NOT_RECRUITING
- Sex
- All
- Target Recruitment
- 500
- Age 20years or older
- Patients who have at least one epicardial coronary artery lesion (including isolated left main disease or side branch) with visually estimated diameter stenosis >50% and take coronary angiography, CT angiography and IVUS
- Willing and able to provide informed written consent
- In-stent restenosis
- Bypass graft
- Suspected coronary spasm even after sufficient nitrate injected
- Cases in which the IVUS imaging catheter failed to cross the lesion
- Poor quality IVUS or CT images
- Visible collateral flow on angiography
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Arm && Interventions
Group Intervention Description IVUS-CAMS Intravascular Ultrasound, coronary computed tomography angiography patients who undergo coronary computed tomography angiography, invasive coronary angiography and IVUS
- Primary Outcome Measures
Name Time Method mathematically-predicted ischemic size (by using IVUS parameters) vs. CAMS-derived myocardial size subtended to the stenotic segment 1 year
- Secondary Outcome Measures
Name Time Method Impact of plaque characteristics (attenuated plaque, plaque rupture, calcification, thrombosis, etc.) assessed by IVUS on the ischemic burden assessed by CAMS 1 year Incidence of MACE comprising death, nonfatal myocardial infarction or target vessel revascularization 1 year
Trial Locations
- Locations (12)
Hallym University Sacred Heart hospital
🇰🇷Anyang, Korea, Republic of
Asan Medical Center
🇰🇷Seoul, Songpa-Gu, Korea, Republic of
Gangneung Asan Hospital
🇰🇷Gangneung, Korea, Republic of
Hallym University Dongtan Sacred Heart Hospital
🇰🇷Gyeonggi-do, Korea, Republic of
Chungnam National University Hospital
🇰🇷Daejeon, Korea, Republic of
Pusan National University Hospital
🇰🇷Pusan, Korea, Republic of
Inje university Pusan Paik hospital
🇰🇷Pusan, Korea, Republic of
Kangbuk Samsung Hospital
🇰🇷Seoul, Korea, Republic of
Kosin University Gospel Hospital
🇰🇷Pusan, Korea, Republic of
Ulsan University Hospital
🇰🇷Ulsan, Korea, Republic of
Pusan National University Yangsan Hospital
🇰🇷Yangsan, Korea, Republic of
Veterans Hospital Medical Center
🇰🇷Seoul, Korea, Republic of